Compass Therapeutics LLC — Form D

Compass Therapeutics LLC of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2015-07-01. The offering totals $121.0M, of which $16.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (33)

Showing 25 of 33 people.

NameRoleLocation
CARL GORDONDirectorSAN DIEGO, CA
Stephen SquintoDirectorStamford, CT
Errik AndersonDirectorCambridge, MA
Errik AndersonExecutive OfficerCambridge, MA
Errik AndersonPromoterCambridge, MA
Steve TregayDirectorSan Carlos, CA
Ben AuspitzDirectorCambridge, MA
Philip FerneauDirectorHanover, NH
THOMAS J SCHUETZDirectorCAMBRIDGE, MA
THOMAS J SCHUETZExecutive OfficerCAMBRIDGE, MA
THOMAS J SCHUETZPromoterCAMBRIDGE, MA
STEVEN J SQUINTODirectorCAMBRIDGE, MA
CARL J GORDONDirectorCAMBRIDGE, MA
SARA J MANNLEExecutive OfficerCAMBRIDGE, MA
VERED J BISKER-LEIBExecutive OfficerCAMBRIDGE, MA
ERRIK J ANDERSONDirectorCAMBRIDGE, MA
ERRIK J ANDERSONPromoterCAMBRIDGE, MA
BEN J AUSPITZDirectorCAMBRIDGE, MA
BRUCE J STEELDirectorCAMBRIDGE, MA
JEB J LEDELLExecutive OfficerCAMBRIDGE, MA
DAMON J BANKSExecutive OfficerCAMBRIDGE, MA
WILL J EDENDirectorCAMBRIDGE, MA
PIOTR J BOBROWICZExecutive OfficerCAMBRIDGE, MA
STEVE J TREGAYDirectorCAMBRIDGE, MA
PHILIP J FERNEAUDirectorCAMBRIDGE, MA

Other filings by this issuer (5)

FiledFormOfferingSold
2018-07-16D/A$170.2M$110.2M
2018-01-08D$50.0M$21.8M
2016-09-21D/A$170.2M$46.0M
2015-05-28D/A$1.0M$575K
2014-06-13D$1.0M$475K

More